School of Chemistry, Bangor University, Bangor, Gwynedd, Wales LL57 2DG, UK.
Toxins (Basel). 2013 Aug 6;5(8):1381-91. doi: 10.3390/toxins5081381.
Botulinum neurotoxins are one of the most potent toxins known to man. Current methods of detection involve the quantification of the toxin but do not take into account the percentage of the toxin that is active. At present the assay used for monitoring the activity of the toxin is the mouse bioassay, which is lengthy and has ethical issues due to the use of live animals. This report demonstrates a novel assay that utilises the endopeptidase activity of the toxin to detect Botulinum neurotoxin in a pharmaceutical sample. The cleaving of SNAP-25 is monitored via UV-Visible spectroscopy with a limit of detection of 373 fg/mL and has been further developed into a high throughput method using a microplate reader detecting down to 600 fg/mL of active toxin. The results show clear differences between the toxin product and the placebo, which contains the pharmaceutical excipients human serum albumin and lactose, showing that the assay detects the active form of the toxin.
肉毒杆菌神经毒素是已知的人类最致命的毒素之一。目前的检测方法涉及到毒素的定量,但没有考虑到毒素的活性百分比。目前用于监测毒素活性的检测方法是小鼠生物测定法,由于使用了活体动物,该方法耗时且存在伦理问题。本报告展示了一种利用毒素的内切酶活性来检测药物样品中肉毒杆菌神经毒素的新方法。通过紫外可见光谱监测 SNAP-25 的切割,检测限为 373 fg/mL,并进一步开发了一种使用微孔板读数器的高通量方法,可检测低至 600 fg/mL 的活性毒素。结果表明,毒素产品与安慰剂之间存在明显差异,安慰剂中含有药物赋形剂人血清白蛋白和乳糖,表明该检测方法可检测到毒素的活性形式。